Half Dose DOAC for Long Term VTE Prevention, Biomarker Guided Antibiotics for Sepsis, GPT-4 Assistance for Physicians, Optimal Vasopressin Initiation for Shock, DOAC vs No AC for A fib After Intracerebral Hemorrhage, HFNC vs NIV for Respiratory Failure
Last Week in Medicine
00:00
Evaluating Antibiotic Use in Sepsis and VTE Management
This chapter examines a trial contrasting the efficacy of apixaban and rivaroxaban for long-term venous thromboembolism prevention, while emphasizing the need for individualized patient care. It also explores the ADAPT sepsis trial, which investigates the use of biomarkers like procalcitonin and CRP in guiding antibiotic durations, alongside discussions on statistical interpretations and their implications for clinical practices. Ultimately, the speakers express skepticism about the trial findings and the future application of these biomarkers in antibiotic stewardship.
Play episode from 18:02
Transcript
